Steroids as procarcinogenic agents

被引:11
作者
Bradlow, HL
Sepkovic, DW
机构
[1] HUMC, David & Alice Jurist Inst Biomed Res, Hackensack, NJ 07601 USA
[2] Univ Med & Dent New Jersey, Hackensack, NJ 07601 USA
来源
SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS | 2004年 / 1028卷
关键词
steroids; progesterone; androgens; estrogen; carcinogenesis;
D O I
10.1196/annals.1322.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although hormones produced in the body are normally considered to be beneficial in such matters as life, male and female development, fertility, and blood pressure regulation, these same compounds can act in some circumstances as carcinogens or carcinogen facilitators, In some such cases increased amounts of the hormone or changes in the formation of its metabolites might be responsible. In other cases the timing of hormone release plays a critical role. In some cases the hormone acts independently, while in others two or more compounds act in concert to promote cancer. The various compounds will be discussed separately, since they usually cause different kinds of cancer. Of the various hormones produced in the body, only aldosterone does not cause any cancers, although excess aldosterone can cause Conn ' s syndrome, which may be detected by the resultant hypertension.
引用
收藏
页码:216 / 232
页数:17
相关论文
共 89 条
[11]   Dehydroepiandrosterone sulfate causes proliferation of estrogen receptor-positive breast cancer cells despite treatment with fulvestrant [J].
Calhoun, KE ;
Pommier, RF ;
Muller, P ;
Fletcher, WS ;
Toth-Fejel, S .
ARCHIVES OF SURGERY, 2003, 138 (08) :879-882
[12]   Estrogen metabolites and the risk of breast cancer in older women [J].
Cauley, JA ;
Zmuda, JM ;
Danielson, ME ;
Ljung, BM ;
Bauer, DC ;
Cummings, SR ;
Kuller, LH .
EPIDEMIOLOGY, 2003, 14 (06) :740-744
[13]   Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases [J].
Cavalieri, EL ;
Li, KM ;
Balu, N ;
Saeed, M ;
Devanesan, P ;
Higginbotham, S ;
Zhao, J ;
Gross, ML ;
Rogan, EG .
CARCINOGENESIS, 2002, 23 (06) :1071-1077
[14]  
CHAN C, 2003, CANCER EPIDEM BIOMAR, V12, P1410
[15]  
Cronauer MV, 2003, INT J ONCOL, V23, P1095
[16]   Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth [J].
Dai, DH ;
Litman, ES ;
Schonteich, E ;
Leslie, KK .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 87 (2-3) :123-131
[17]  
De Vivo I, 2003, CANCER RES, V63, P5236
[18]  
DUPONT E, 2000, ANN SURG ONCOL S1, V7, P35
[19]  
Fleisher M, 1996, CLIN CHEM, V42, P689
[20]   Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection [J].
Fowke, JH ;
Qi, D ;
Bradlow, HL ;
Shu, XO ;
Gao, YT ;
Cheng, JR ;
Jin, F ;
Zheng, W .
STEROIDS, 2003, 68 (01) :65-72